Primigravidae and secundigravidae women presenting with an uncomplicated malaria attack will be randomly treated with CQ or SP and regularly followed up to assess clinical and parasitological efficacy. A molecular analysis of parasite gene mutations conferring resistance to chloroquine (PfCRT), and antifolates (DHFR, DHPS) will be performed.